Publications
Antonio Pagliuca:
- Pre-symptomatic (Baseline) computed tomography predicts invasive pulmonary aspergillosis in high-risk adult haemato-oncology patients.
Ceesay MM, Desai SR, Cleverley J, Berry L, Smith M, Wade J, Mufti GJ, Pagliuca A.
Br J Haematol 2018; 182(5): 723-7 - ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients.
Cesaro S, Dalianis T, Hanssen Rinaldo C, Koskenvuo M, Pegoraro A, Einsele H, Cordonnier C, Hirsch HH.
J Antimicrob Chemother 2018; 73(1): 12-21
- Cancer immunotherapy with CAR-T cells - behold the future.
Graham C, Hewitson R, Pagliuca A, Benjamin R.
Clin Med (Lond) 2018; 18(4): 324-8 - The Impact of Advanced Patient Age on Mortality after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma: A Retrospective Study by the European Society for Blood and Marrow Transplantation Lymphoma Working Party.
Kyriakou C, Boumendil A, Finel H, Nn Norbert S, Andersen NS, Blaise D, Chevallier P, Browne P, Malladi R, Niederwieser D, Pagliuca A, Kroschinsky F, Montoto S, Dreger P.
Biol Blood Marrow Transplant 2019; 25(1): 86-93 - European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia.
Maertens JA, Girmenia C, Bruggemann RJ, Duarte RF, Kibbler CC, Ljungman P, Racil Z, Ribaud P, Slavin MA, Cornely OA, Peter Donnelly J, Cordonnier C.
J Antimicrob Chemother 2018; 73(12): 3221-30 - Heterozygous RTEL1 variants in bone marrow failure and myeloid neoplasms.
Marsh JCW, Gutierrez-Rodrigues F, Cooper J, Jiang J, Gandhi S, Kajigaya S, Feng X, Ibanez M, Donaires FS, Lopes da Silva JP, Li Z, Das S, Ibanez M, Smith AE, Lea N, Best S, Ireland R, Kulasekararaj AG, McLornan DP, Pagliuca A, Callebaut I, Young NS, Calado RT, Townsley DM, Mufti GJ.
Blood Adv 2018; 2(1): 36-48 - Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines.
Mikulska M, Averbuch D, Tissot F, Cordonnier C, Akova M, Calandra T, Ceppi M, Bruzzi P, Viscoli C.
J Infect 2018; 76(1): 20-37 - Alemtuzumab vs anti-thymocyte globulin in patients transplanted from an unrelated donor after a reduced intensity conditioning.
Robin M, Raj K, Chevret S, Gauthier J, de Lavallade H, Michonneau D, McLornan D, Peffault de Latour R, Potter V, Kulasekararaj A, Sicre de Fontbrune F, Pagliuca A, Yakoub-Agha I, Socie G, Mufti GJ.
Eur J Haematol 2018; 101(4): 466-74 - Anti-type M phospholipase A2 receptor antibody-positive membranous nephropathy as a part of multi-system autoimmune syndrome post-allogeneic stem cell transplantation.
Tedjaseputra A, McLornan D, McCormick J, Raj K, de Lavallade H, Potter V, Kenyon M, Pagliuca A, Marsh J, Mufti G.
Intern Med J 2018; 48(4): 481-3 - Circulating Aspergillus fumigatus DNA Is Quantitatively Correlated to Galactomannan in Serum.
Alanio A, Stephane Bretagne, Menotti J, Gits-Muselli M, Hamane S, Denis B, Rafoux E, Peffault de la Tour R, Touratier S, Bergeron A, Guigue N, Bretagne S.
Front Microbiol 2017; 8: 2040 - Impact of alternative treatment approach for cerebral toxoplasmosis among HIV/AIDS patients from a resource-poor setting in Burkina Faso.
Bamba S, Zoungrana J, Nikiema Z, Sondo AK, Ndiaye JL, Bretagne S.
Ann Parasitol 2017; 63(3): 173-81 - ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients.
Cesaro S, Dalianis T, Hanssen Rinaldo C, Koskenvuo M, Pegoraro A, Einsele H, Cordonnier C, Hirsch HH.
J Antimicrob Chemother 2018; 73(1): 12-21 - In Vitro and In Vivo Efficacy of a Novel and Long-Acting Fungicidal Azole, PC1244, on Aspergillus fumigatus Infection.
Colley T, Sehra G, Chowdhary A, Alanio A, Kelly SL, Kizawa Y, Armstrong-James D, Fisher MC, Warrilow AGS, Parker JE, Kelly DE, Kimura G, Nishimoto Y, Sunose M, Onions S, Crepin D, Lagasse F, Crittall M, Shannon J, McConville M, King-Underwood J, Naylor A, Bretagne S, Murray J, Ito K, Strong P, Rapeport G.
Antimicrob Agents Chemother 2018; 62(5) - Candiduria in kidney transplant recipients: Is antifungal therapy useful?
Denis B, Chopin D, Piron P, Resche-Rigon M, Bretagne S, Gits-Muselli M, Peraldi MN, Abboud I, Molina JM.
Mycoses 2018; 61(5): 298-304 - Population Structure of Candida parapsilosis: No Genetic Difference Between French and Uruguayan Isolates Using Microsatellite Length Polymorphism.
Desnos-Ollivier M, Bormida V, Poirier P, Nourrisson C, Pan D, Bretagne S, Puime A, Dromer F.
Mycopathologia 2018; 183(2): 381-90 - Outcome and potentially modifiable risk factors for candidemia in critically ill burns patients: A matched cohort study.
Dudoignon E, Alanio A, Anstey J, Depret F, Coutrot M, Fratani A, Jully M, Cupaciu A, Chaussard M, Oueslati H, Ferry A, Benyamina M, de Tymowski C, Boccara D, Serror K, Chaouat M, Mimoun M, Lafaurie M, Denis B, Gits-Muselli M, Bretagne S, Mebazaa A, Legrand M, Soussi S.
Mycoses 2019; 62(3): 237-46 - Outbreak of Invasive Wound Mucormycosis in a Burn Unit Due to Multiple Strains of Mucor circinelloides f. circinelloides Resolved by Whole-Genome Sequencing.
Garcia-Hermoso D, Criscuolo A, Lee SC, Legrand M, Chaouat M, Denis B, Lafaurie M, Rouveau M, Soler C, Schaal JV, Mimoun M, Mebazaa A, Heitman J, Dromer F, Brisse S, Bretagne S, Alanio A.
MBio 2018; 9(2) - Continuous Decline of Toxoplasma gondii Seroprevalence in Hospital: A 1997-2014 Longitudinal Study in Paris, France.
Guigue N, Leon L, Hamane S, Gits-Muselli M, Le Strat Y, Alanio A, Bretagne S.
Front Microbiol 2018; 9: 2369 - European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia.
Maertens JA, Girmenia C, Bruggemann RJ, Duarte RF, Kibbler CC, Ljungman P, Racil Z, Ribaud P, Slavin MA, Cornely OA, Peter Donnelly J, Cordonnier C.
J Antimicrob Chemother 2018; 73(12): 3221-30 - Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines.
Mikulska M, Averbuch D, Tissot F, Cordonnier C, Akova M, Calandra T, Ceppi M, Bruzzi P, Viscoli C.
J Infect 2018; 76(1): 20-37 - Failure of voriconazole therapy due to acquired azole resistance in Aspergillus fumigatus in a kidney transplant recipient with chronic necrotizing aspergillosis.
Pilmis B, Garcia-Hermoso D, Alanio A, Catherinot E, Scemla A, Jullien V, Bretagne S, Lortholary O.
Am J Transplant 2018; 18(9): 2352-5 - Mainly Post-Transplant Factors Are Associated with Invasive Aspergillosis after Allogeneic Stem Cell Transplantation: A Study from the Surveillance des Aspergilloses Invasives en France and Societe Francophone de Greffe de Moelle et de Therapie Cellulaire.
Robin C, Cordonnier C, Sitbon K, Raus N, Lortholary O, Maury S, Peffault de la Tour R, Bretagne S, Bastuji-Garin S.
Biol Blood Marrow Transplant 2019; 25(2): 354-61 - Primary antifungal prophylaxis with micafungin after allogeneic hematopoietic stem cell transplantation: a monocentric prospective study.
Xhaard A, Porcher R, Bergeron A, Alanio A, Touratier S, Bretagne S, de Margerie-Mellon C, Sicre de Fontbrune F, Itzykson R, Coman T, Robin M, Cabannes-Hamy A, Socie G, Peffault de Latour R.
Ann Hematol 2019; 98(4): 1033-5
Rafael F. Duarte:
- Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT.
Buchbinder D, Kelly DL, Duarte RF, Auletta JJ, Bhatt N, Byrne M, DeFilipp Z, Gabriel M, Mahindra A, Norkin M, Schoemans H, Shah AJ, Ahmed I, Atsuta Y, Basak GW, Beattie S, Bhella S, Bredeson C, Bunin N, Dalal J, Daly A, Gajewski J, Gale RP, Galvin J, Hamadani M, Hayashi RJ, Adekola K, Law J, Lee CJ, Liesveld J, Malone AK, Nagler A, Naik S, Nishihori T, Parsons SK, Scherwath A, Schofield HL, Soiffer R, Szer J, Twist I, Warwick AB, Wirk BM, Yi J, Battiwalla M, Flowers MDE, Savani B, Shaw BE.
Bone Marrow Transplant 2018; 53(5): 535-55 - Novel approaches to CMV after HCT: report from the 27th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria, 22-25 April 2017.
Duarte RF, Lyon S.
Future Sci OA 2018; 4(5): Fso296 - Health-care professionals' perspective on discussing sexual issues in adult patients after haematopoietic cell transplantation.
Eeltink CM, Witte BI, Stringer J, Liptrott S, Babic A, Greenfield DM, Salooja N, Incrocci L, Visser O, Verdonck-de Leeuw IM, Duarte RF, Zweegman S.
Bone Marrow Transplant 2018; 53(3): 235-45 - Analysis of the Spanish CCR5-32 inventory of cord blood units: lower cell counts in homozygous donors.
Enrich E, Vidal F, Sanchez-Gordo F, Gomez-Zumaquero JM, Balas A, Rudilla F, Barea L, Castro A, Larrea L, Perez-Vaquero MA, Prat I, Querol S, Garrido G, Matesanz R, Carreras E, Duarte RF.
Bone Marrow Transplant 2018; 53(6): 741-8 - HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia: Results From the Microtransplantation Interest Group.
Guo M, Chao NJ, Li JY, Rizzieri DA, Sun QY, Mohrbacher A, Krakow EF, Sun WJ, Shen XL, Zhan XR, Wu DP, Liu L, Wang J, Zhou M, Yang LH, Bao YY, Dong Z, Cai B, Hu KX, Yu CL, Qiao JH, Zuo HL, Huang YJ, Sung AD, Qiao JX, Liu ZQ, Liu TQ, Yao B, Zhao HX, Qian SX, Liu WW, Fores R, Duarte RF, Ai HS.
JAMA Oncol 2018; 4(1): 54-62 - Chronic graft-versus-host disease features in double unit cord blood transplantation according to National Institutes of Health 2005 cGVHD Consensus criteria.
Hayashi H, Ruggeri A, Volt F, Cornelissen JJ, Socie G, Sengeloev H, Michallet M, Karakasis D, Petersen E, Cahn JY, Veelken H, Mercier M, Rohrlich PS, Rafii H, Kenzey C, Xavier E, Duarte RF, Basak GW, Rocha V, Gluckman E.
Bone Marrow Transplant 2018; 53(4): 417-21 - Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation.
Inamoto Y, Petricek I, Burns L, Chhabra S, DeFilipp Z, Hematti P, Rovo A, Schears R, Shah A, Agrawal V, Ahmed A, Ahmed I, Ali A, Aljurf M, Alkhateeb H, Beitinjaneh A, Bhatt N, Buchbinder D, Byrne M, Callander N, Fahnehjelm K, Farhadfar N, Gale RP, Ganguly S, Hashmi S, Hildebrandt GC, Horn E, Jakubowski A, Kamble RT, Law J, Lee C, Nathan S, Penack O, Pingali R, Prasad P, Pulanic D, Rotz S, Shreenivas A, Steinberg A, Tabbara K, Tichelli A, Wirk B, Yared J, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Valdes-Sanz N.
Biol Blood Marrow Transplant 2018 - Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.
Inamoto Y, Valdes-Sanz N, Ogawa Y, Alves M, Berchicci L, Galvin J, Greinix H, Hale GA, Horn B, Kelly D, Liu H, Rowley S, Schoemans H, Shah A, Lupo Stanghellini MT, Agrawal V, Ahmed I, Ali A, Bhatt N, Byrne M, Chhabra S, DeFilipp Z, Fahnehjelm K, Farhadfar N, Horn E, Lee C, Nathan S, Penack O, Prasad P, Rotz S, Rovo A, Yared J, Pavletic S, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Petricek I.
Bone Marrow Transplant 2018. - Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Complications and Quality of Life Working Party of the European Society for Blood and Marrow Transplantation.
Kelly DL, Buchbinder D, Duarte RF, Auletta JJ, Bhatt N, Byrne M, DeFilipp Z, Gabriel M, Mahindra A, Norkin M, Schoemans H, Shah AJ, Ahmed I, Atsuta Y, Basak GW, Beattie S, Bhella S, Bredeson C, Bunin N, Dalal J, Daly A, Gajewski J, Gale RP, Galvin J, Hamadani M, Hayashi RJ, Adekola K, Law J, Lee CJ, Liesveld J, Malone AK, Nagler A, Naik S, Nishihori T, Parsons SK, Scherwath A, Schofield HL, Soiffer R, Szer J, Twist I, Warwick A, Wirk BM, Yi J, Battiwalla M, Flowers ME, Savani B, Shaw BE.
Biol Blood Marrow Transplant 2018; 24(2): 228-41 - European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia.
Maertens JA, Girmenia C, Bruggemann RJ, Duarte RF, Kibbler CC, Ljungman P, Racil Z, Ribaud P, Slavin MA, Cornely OA, Peter Donnelly J, Cordonnier C.
J Antimicrob Chemother 2018; 73(12): 3221-30 - Use of defibrotide to treat adult patients with transplant-associated thrombotic microangiopathy.
Martinez-Munoz ME, Fores R, Lario A, Bautista G, Bueno JL, de Miguel C, Navarro B, De Laiglesia A, Sanchez-Guerrero A, Cabrera JR, Duarte RF.
Bone Marrow Transplant 2018. - Recommendations from the European Society for Blood and Marrow Transplantation (EBMT) for a curriculum in hematopoietic cell transplantation.
Mohty M, Duarte RF, Kuball J, Bader P, Basak GW, Bonini C, Carreras E, Chabannon C, Dufour C, Gennery A, Lankester A, Lanza F, Ljungman P, Montoto S, Nagler A, Snowden JA, Styczynski J, Sureda A, Kroger N.
Bone Marrow Transplant 2018; 53(12): 1548-52 - Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT.
Moiseev IS, Tsvetkova T, Aljurf M, Alnounou RM, Bogardt J, Chalandon Y, Drokov MY, Dvirnyk V, Faraci M, Friis LS, Giglio F, Greinix HT, Kornblit BT, Koelper C, Koenecke C, Lewandowski K, Niederwieser D, Passweg JR, Peczynski C, Penack O, Peric Z, Piekarska A, Ronchi PE, Rovo A, Rzepecki P, Scuderi F, Sigrist D, Siitonen SM, Stoelzel F, Sulek K, Tsakiris DA, Wilkowojska U, Duarte RF, Ruutu T, Basak GW.
Bone Marrow Transplant 2018 - Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report.
Passweg JR, Baldomero H, Bader P, Basak GW, Bonini C, Duarte R, Dufour C, Kroger N, Kuball J, Lankester A, Montoto S, Nagler A, Snowden JA, Styczynski J, Mohty M.
Bone Marrow Transplant 2018; 53(9): 1139-48 - Variability of nutritional practices in peritransplant period after allogeneic hematopoietic stem cell transplantation: a survey by the Complications and Quality of Life Working Party of the EBMT.
Peric Z, Botti S, Stringer J, Krawczyk J, van der Werf S, van Biezen A, Aljurf M, Murray J, Liptrott S, Greenfield DM, Duarte RF, Ruutu T, Basak GW.
Bone Marrow Transplant 2018; 53(8): 1030-7 - The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment: a multicenter randomized controlled trial.
Schoemans HM, Goris K, Van Durm R, Fieuws S, De Geest S, Pavletic SZ, Im A, Wolff D, Lee SJ, Greinix H, Duarte RF, Poire X, Selleslag D, Lewalle P, Kerre T, Graux C, Baron F, Maertens JA, Dobbels F.
Haematologica 2018; 103(10): 1698-707 - Accuracy and usability of the eGVHD app in assessing the severity of graft-versus-host disease at the 2017 EBMT annual congress.
Schoemans HM, Goris K, Van Durm R, Vanbrabant K, De Geest S, Maertens J, Wolff D, Greinix H, Ruutu T, Pavletic SZ, Im A, Lee SJ, Basak GW, Duarte RF, Dobbels F.
Bone Marrow Transplant 2018; 53(4): 490-4 - EBMT-NIH-CIBMTR Task Force
position statement on standardized terminology & guidance for graft-versus-host disease assessment.
Schoemans HM, Lee SJ, Ferrara JL, Wolff D, Levine JE, Schultz KR, Shaw BE, Flowers ME, Ruutu T, Greinix H, Holler E, Basak G, Duarte RF, Pavletic SZ.
Bone Marrow Transplant 2018; 53(11): 1401-15 - Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European Patients.
Tichelli A, Beohou E, Labopin M, Socie G, Rovo A, Badoglio M, van Biezen A, Bader P, Duarte RF, Basak G, Salooja N.
JAMA Oncol 2018
Oliver A. Cornely:
- Corrigendum: Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?
Zoran T, Sartori B, Sappl L, Aigner M, Sanchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Lo Cascio G, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernandez MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Sabino R, Lass-Florl C, Lackner M.
Front Microbiol 2018; 9: 3245 - Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?
Zoran T, Sartori B, Sappl L, Aigner M, Sanchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Lo Cascio G, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernandez MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Lass-Florl C, Lackner M.
Frontiers in Microbiology 2018; 9: 9 - Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial.
Wunderink RG, Giamarellos-Bourboulis EJ, Rahav G, Mathers AJ, Bassetti M, Vazquez J, Cornely OA, Solomkin J, Bhowmick T, Bishara J, Daikos GL, Felton T, Furst MJL, Kwak EJ, Menichetti F, Oren I, Alexander EL, Griffith D, Lomovskaya O, Loutit J, Zhang S, Dudley MN, Kaye KS.
Infect Dis Ther 2018; 7(4): 439-55 - Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial.
Winston DJ, Mullane KM, Cornely OA, Boeckh MJ, Brown JW, Pergam SA, Trociukas I, Zak P, Craig MD, Papanicolaou GA, Velez JD, Panse J, Hurtado K, Fernsler DA, Stek JE, Pang L, Su SC, Zhao YL, Chan ISF, Kaplan SS, Parrino J, Lee I, Popmihajlov Z, Annunziato PW, Arvin A, Team VPT.
Lancet 2018; 391(10135): 2116-27 - Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Florl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Bruggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Loffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinko J, Skiada A, Vehreschild M, Viscoli C, Cornely OA.
Clin Microbiol Infect 2018; 24 Suppl 1: e1-e38 - Food Intake Recruits Orosensory and Post-ingestive Dopaminergic Circuits to Affect Eating Desire in Humans.
Thanarajah SE, Backes H, DiFeliceantonio AG, Albus K, Cremer AL, Hanssen R, Lippert RN, Cornely OA, Small DM, Bruning JC, Tittgemeyer M.
Cell Metab 2018 - A Comparison of Aspergillus and Mucorales PCR Testing of Different Bronchoalveolar Lavage Fluid Fractions from Patients with Suspected Invasive Pulmonary Fungal Disease.
Springer J, White PL, Kessel J, Wieters I, Teschner D, Korczynski D, Liebregts T, Cornely OA, Schwartz S, Elgeti T, Meintker L, Krause SW, Posso RB, Heinz WJ, Fuhrmann S, Vehreschild JJ, Einsele H, Rickerts V, Loeffler J.
Journal of Clinical Microbiology 2018; 56(2): 8 - Identification of Aspergillus and Mucorales in formalin-fixed, paraffin-embedded tissue samples: Comparison of specific and broad-range fungal qPCR assays.
Springer J, McCormick Smith I, Hartmann S, Winkelmann R, Wilmes D, Cornely O, Kessel J, Loffler J, Rickerts V.
Med Mycol 2018 - EQUAL Cryptococcus Score 2018: A European Confederation of Medical Mycology Score Derived From Current Guidelines to Measure QUALity of Clinical Cryptococcosis Management.
Spec A, Mejia-Chew C, Powderly WG, Cornely OA.
Open Forum Infect Dis 2018; 5(11): ofy299 - Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).
Schmidt-Hieber M, Bierwirth J, Buchheidt D, Cornely OA, Hentrich M, Maschmeyer G, Schalk E, Vehreschild JJ, Vehreschild M, Grp AW.
Annals of Hematology 2018; 97(1): 31-49 - Diagnosis and Management of Systemic Endemic Mycoses Causing Pulmonary Disease.
Salzer HJF, Burchard G, Cornely OA, Lange C, Rolling T, Schmiedel S, Libman M, Capone D, Le T, Dalcolmo MP, Heyckendorf J.
Respiration 2018: 1-19 - Anti-infective Vaccination Strategies in Patients with Hematologic Malignancies or Solid Tumors - Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO).
Rieger CT, Liss B, Mellinghoff S, Buchheidt D, Cornely OA, Egerer G, Heinz WJ, Hentrich M, Maschmeyer G, Mayer K, Sandherr M, Silling G, Ullmann A, Vehreschild M, von Lilienfeld-Toal M, Wolf HH, Lehners N.
Ann Oncol 2018 - Molecular diagnostic strategies in cancer patients with suspected respiratory mold infections.
Rickerts V, Springer J, Kessel J, Teschner D, Liebregts T, Cornely OA, Schwartz S, Willinger B, Meintker L, Gerkrath J, Wilmes D, Vehreschild JJ, Einsele H, Loffler J.
Medical Mycology 2018; 56: S68-S - Comparison of Two Molecular Assays for Detection and Characterization of Aspergillus fumigatus Triazole Resistance and Cyp51A Mutations in Clinical Isolates and Primary Clinical Samples of Immunocompromised Patients.
Postina P, Skladny J, Boch T, Cornely OA, Hamprecht A, Rath PM, Steinmann J, Bader O, Miethke T, Dietz A, Merker N, Hofmann WK, Buchheidt D, Spiess B.
Frontiers in Microbiology 2018; 9: 9 - Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial.
Perfect JR, Cornely OA, Heep M, Ostrosky-Zeichner L, Mullane KM, Maher R, Croos-Dabrera R, Lademacher C, Engelhardt M, Chen C, Marty FM.
Mycoses 2018; 61(7): 420-9 - The role of medical mycology societies in combating invasive fungal infections in low- and middle-income countries: A Nigerian model.
Oladele RO, Osaigbovo, II, Ayanlowo OO, Otu AA, Hoenigl M, Cornely OA, Chakrabarti A, Denning DW.
Mycoses 2018 - Epidemiology of Surgical Site Infections With Staphylococcus aureus in Europe: Protocol for a Retrospective, Multicenter Study.
Mellinghoff SC, Vehreschild JJ, Liss BJ, Cornely OA.
JMIR Res Protoc 2018; 7(3): e63 - Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
Mellinghoff SC, Panse J, Alakel N, Behre G, Buchheidt D, Christopeit M, Hasenkamp J, Kiehl M, Koldehoff M, Krause SW, Lehners N, von Lilienfeld-Toal M, Lohnert AY, Maschmeyer G, Teschner D, Ullmann AJ, Penack O, Ruhnke M, Mayer K, Ostermann H, Wolf HH, Cornely OA.
Ann Hematol 2018; 97(2): 197-207 - Mucormycosis in patients with diabetes mellitus.
Mellinghoff SC, Kohler P, Seidel D, Cornely OA.
Diabetologe 2018; 14(3): 153-9 - EQUAL Candida Score: An ECMM score derived from current guidelines to measure QUAlity of Clinical Candidaemia Management.
Mellinghoff SC, Hoenigl M, Koehler P, Kumar A, Lagrou K, Lass-Florl C, Meis JF, Menon V, Rautemaa-Richardson R, Cornely OA.
Mycoses 2018; 61(5): 326-30 - Analyzing candidemia guideline adherence identifies opportunities for antifungal stewardship.
Mellinghoff SC, Hartmann P, Cornely FB, Knauth L, Kohler F, Kohler P, Krause C, Kronenberg C, Kranz SL, Menon V, Muller H, Naendrup JH, Putzfeld S, Ronge A, Rutz J, Seidel D, Wisplinghoff H, Cornely OA.
European Journal of Clinical Microbiology & Infectious Diseases 2018; 37(8): 1563-71 - Essentials in Candida bloodstream infection.
Mellinghoff SC, Cornely OA, Jung N.
Infection 2018; 46(6): 897-9 - Isavuconazole shortens the QTc interval.
Mellinghoff SC, Bassetti M, Dorfel D, Hagel S, Lehners N, Plis A, Schalk E, Vena A, Cornely OA.
Mycoses 2018; 61(4): 256-60 - Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species.
Marty FM, Cornely OA, Mullane KM, Ostrosky-Zeichner L, Maher RM, Croos-Dabrera R, Lu QY, Lademacher C, Oren I, Schmitt-Hoffmann AH, Giladi M, Rahav G, Perfect JR.
Mycoses 2018; 61(7): 485-97 - European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia.
Maertens JA, Girmenia C, Bruggemann RJ, Duarte RF, Kibbler CC, Ljungman P, Racil Z, Ribaud P, Slavin MA, Cornely OA, Peter Donnelly J, Cordonnier C.
J Antimicrob Chemother 2018 - Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole.
Maertens J, Selleslag D, Heinz WJ, Saulay M, Rahav G, Giladi M, Aoun M, Kovanda L, Kaufhold A, Engelhardt M, Cornely OA, Herbrecht R, Ullmann AJ.
Mycoses 2018 - Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial.
Kontoyiannis DP, Selleslag D, Mullane K, Cornely OA, Hope W, Lortholary O, Croos-Dabrera R, Lademacher C, Engelhardt M, Patterson TF.
Journal of Antimicrobial Chemotherapy 2018; 73(3): 757-63 - EQUAL mucormycosis score 2018: An ECMM score derived from current guidelines to measure quality of mucormycosis management in hematology.
Koehler P, Mellinghoff S, Alanio A, Arenz D, Hoenigl M, Lagrou K, Lass-Floerl C, Meis J, Richardson M, Cornely OA.
Mycoses 2018; 61: 34- - EQUAL Aspergillosis Score 2018: An ECMM score derived from current guidelines to measure QUALity of the clinical management of invasive pulmonary aspergillosis.
Koehler P, Cornely OA, Arenz D, Mellinghoff S.
Mycoses 2018; 61: 33- - Candida-reactive T cells for the diagnosis of invasive Candida infection.
Koehler FC, Cornely OA, Wisplinghoff H, Schauss AC, Salmanton-Garcia J, Ostermann H, Ziegler M, Bacher P, Scheffold A, Alex R, Richter A, Koehler P.
Medical Mycology 2018; 56: S85-S - Candida-Reactive T Cells for the Diagnosis of Invasive Candida Infection-A Prospective Pilot Study.
Koehler FC, Cornely OA, Wisplinghoff H, Schauss AC, Salmanton-Garcia J, Ostermann H, Ziegler M, Bacher P, Scheffold A, Alex R, Richter A, Koehler P.
Front Microbiol 2018; 9: 1381 - Candida-reactive T cells for the diagnosis of invasive Candida infection of the lumbar vertebral spine.
Koehler FC, Cornely OA, Wisplinghoff H, Chang DH, Richter A, Koehler P.
Mycoses 2018; 61(1): 48-52 - Rare Mold Infections Caused by Mucorales, Lomentospora Prolificans and Fusarium, San Diego: The Role of Antifungal Combination Therapy.
Jenks JD, Reed SL, Seidel D, Koehler P, Cornely OA, Mehta SR, Hoenigl M.
Int J Antimicrob Agents 2018 - Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together.
Hoenigl M, Gangneux JP, Segal E, Alanio A, Chakrabarti A, Chen SC, Govender N, Hagen F, Klimko N, Meis JF, Pasqualotto AC, Seidel D, Walsh TJ, Lagrou K, Lass-Florl C, Cornely OA.
Mycoses 2018; 61(11): 885-94 - Healthcare Burden of Probable and Proven Invasive Mucormycosis: A Multicenter Cost-of-Illness Analysis of Patients Treated in Tertiary Care Hospitals between 2003 - 2016.
Heimann SM, Vehreschild M, Cornely OA, Heinz WJ, Gruner B, Silling G, Kessel J, Seidel D, Vehreschild JJ.
J Hosp Infect 2018 - Chlorhexidine-containing dressings in the prevention of central venous catheter-related bloodstream infections: A cost and resource utilization analysis.
Heimann SM, Biehl LM, Vehreschild JJ, Franke B, Cornely OA, Vehreschild M.
Am J Infect Control 2018 - Candida auris in Germany - report of the first clinical cases of an emerging nosocomial pathogen.
Hamprecht AG, Martin R, Mellinghoff SC, Walther G, Cornely OA, Kurzai O.
Medical Mycology 2018; 56: S32-S - Candida auris in Germany - report of the first cases.
Hamprecht A, Martin R, Mellinghoff S, Walther G, Cornely OA, Kurzai O.
Mycoses 2018; 61: 9- - Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial. |
Guery B, Menichetti F, Anttila VJ, Adomakoh N, Aguado JM, Bisnauthsing K, Georgopali A, Goldenberg SD, Karas A, Kazeem G, Longshaw C, Palacios-Fabrega JA, Cornely OA, Vehreschild M, Grp ECS.
Lancet Infectious Diseases 2018; 18(3): 296-307 - Novel bi-allelic splice mutations in CARD9 causing adult-onset Candida endophthalmitis.
Gavino C, Mellinghoff S, Cornely OA, Landekic M, Le C, Langelier M, Golizeh M, Proske S, Vinh DC.
Mycoses 2018; 61(1): 61-5 - Pharmacokinetic Modeling of Voriconazole To Develop an Alternative Dosing Regimen in Children.
Gastine S, Lehrnbecher T, Muller C, Farowski F, Bader P, Ullmann-Moskovits J, Cornely OA, Groll AH, Hempel G.
Antimicrobial Agents and Chemotherapy 2018; 62(1): 13 - Impact of choice, timing, sequence and combination of broad-spectrum antibiotics on the outcome of allogeneic haematopoietic stem cell transplantation.
Farowski F, Bucker V, Vehreschild JJ, Biehl L, Cruz-Aguilar R, Scheid C, Holtick U, Jazmati N, Wisplinghoff H, Cornely OA, Vehreschild M.
Bone Marrow Transplantation 2018; 53(1): 52-7 - Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients aged >/=60 years (EXTEND): analysis of cost-effectiveness.
Cornely OA, Watt M, McCrea C, Goldenberg SD, De Nigris E.
J Antimicrob Chemother 2018 - Isavuconazole for treatment of rare invasive fungal diseases.
Cornely OA, Mullane KM, Ostrosky-Zeichner L, Maher RM, Croos-Dabrera R, Lu QY, Lademacher C, Perfect JR, Oren I, Schmitt-Hoffmann AH, Giladi M, Marty FM, Rahav G.
Mycoses 2018; 61(8): 518-33 - How to prophylax against invasive fungal infections in adult ALL? An unmet need.
Cornely OA, Kontoyiannis DP.
Mycoses 2018 - EQUAL Aspergillosis Score 2018: An ECMM score derived from current guidelines to measure QUALity of the clinical management of invasive pulmonary aspergillosis.
Cornely OA, Koehler P, Arenz D, S CM.
Mycoses 2018 - Attributable Mortality of Candidemia after Introduction of Echinocandines.
Cornely F, Cornely OA, Koehler P, Kohler F, Mellinghoff S.
Mycoses 2018; 61: 33- - (1,3)-beta-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): study protocol for a randomized controlled trial.
Bloos F, Held J, Schlattmann P, Brillinger N, Kurzai O, Cornely OA, Thomas-Ruddel D.
Trials 2018; 19(1): 472 - Bezlotoxumab Is Associated With a Reduction in Cumulative Inpatient-Days: Analysis of the Hospitalization Data From the MODIFY I and II Clinical Trials.
Basu A, Prabhu VS, Dorr MB, Golan Y, Dubberke ER, Cornely OA, Heimann SM, Pedley A, Xu R, Hanson ME, Marcella S.
Open Forum Infect Dis 2018; 5(11): ofy218 - What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead.
Bassetti M, Righi E, Montravers P, Cornely OA.
Journal of Antimicrobial Chemotherapy 2018; 73: i14-i25 - PCR-based approach targeting Mucorales specific gene family for the diagnosis of mucormycosis.
Baldin C, Soliman SSM, Jeon HH, Alkhazraji S, Gebremariam T, Gu Y, Bruno VM, Cornely OA, Leather HL, Sugrue MW, Wingard JR, Stevens DA, Edwards JE, Jr., Ibrahim AS.
J Clin Microbiol 2018
Livio Pagano:
- Infections in Myelodysplastic Syndrome in Relation to Stage and Therapy.
Leone G, Pagano L.
Mediterr J Hematol Infect Dis 2018; 10(1): e2018039 - Therapy-related myeloid neoplasms: clinical perspectives.
Fianchi L, Criscuolo M, Fabiani E, Falconi G, Maraglino AME, Voso MT, Pagano L.
Onco Targets Ther 2018; 11: 5909-15 - Invasive Fungal Infections in Patients with Chronic Lymphoproliferative Disorders in the Era of Target Drugs.
Facchinelli D, Marchesini G, Nadali G, Pagano L.
Mediterr J Hematol Infect Dis 2018; 10(1): e2018063 - Febrile events in acute lymphoblastic leukemia: a prospective observational multicentric SEIFEM study (SEIFEM-2012/B ALL).
Di Blasi R, Cattaneo C, Lewis RE, Tumbarello M, Angelici L, Dragonetti G, Busca A, Cambo B, Candoni A, Cesarini M, Cesaro S, Delia M, Fanci R, Farina F, Garzia M, Giordano A, Martino B, Melillo L, Nadali G, Perriello V, Picardi M, Quinto AM, Salutari P, Spolzino A, Vacca A, Vetro C, Zancanella M, Nosari A, Aversa F, Pagano L.
Ann Hematol 2018; 97(5): 791-8 - Diagnostic-driven antifungal approach in neutropenic patients at high risk for chronic disseminated candidiasis: preliminary observations on the role of 1,3-beta-D-glucan antigenemia and multiphasic contrast-enhanced computed tomography.
Della Pepa R, Cerchione C, Pugliese N, Colicchio R, Salvatore P, Sirignano C, Soscia E, Pagano L, Sanguinetti M, Pane F, Picardi M.
Support Care Cancer 2018; 26(6): 1691-4 - Allogeneic Transplant for Mycosis Fungoides in Patient with Wiskott-Aldrich Syndrome.
Criscuolo M, Fianchi L, Chiusolo P, Giammarco S, Bacigalupo A, Pagano L.
J Clin Immunol 2018; 38(1): 7-9 - Prophylaxis for aspergillosis in patients with haematological malignancies: pros and cons.
Busca A, Pagano L.
Expert Rev Anti Infect Ther 2018; 16(7): 531-42 - SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disorders.
Busca A, Cesaro S, Teofili L, Delia M, Cattaneo C, Criscuolo M, Marchesi F, Fracchiolla NS, Valentini CG, Farina F, Di Blasi R, Prezioso L, Spolzino A, Candoni A, Del Principe MI, Verga L, Nosari A, Aversa F, Pagano L.
Expert Rev Hematol 2018; 11(2): 155-68 - Estimated burden of fungal infections in Italy.
Bassetti M, Carnelutti A, Peghin M, Aversa F, Barchiesi F, Girmenia C, Pagano L, Sanguinetti M, Tortorano AM, Montagna MT, Viale P, Viscoli C, Denning DW.
J Infect 2018; 76(1): 103-6 - Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid.
Autore F, Chiusolo P, Sora F, Giammarco S, Laurenti L, Innocenti I, Metafuni E, Piccirillo N, Pagano L, Bacigalupo A, Leone G, Sica S.
Leuk Lymphoma 2018: 1-3 - Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria.
Cattaneo C, Di Blasi R, Skert C, Candoni A, Martino B, Di Renzo N, Delia M, Ballanti S, Marchesi F, Mancini V, Orciuolo E, Cesaro S, Prezioso L, Fanci R, Nadali G, Chierichini A, Facchini L, Picardi M, Malagola M, Orlando V, Trecarichi EM, Tumbarello M, Aversa F, Rossi G, Pagano L.
Ann Hematol 2018; 97(9): 1717-26 - Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Florl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Bruggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Loffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinko J, Skiada A, Vehreschild M, Viscoli C, Cornely OA.
Clin Microbiol Infect 2018; 24 Suppl 1: e1-e38 - SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis.
Martinelli G, Mancini M, De Benedittis C, Rondoni M, Papayannidis C, Manfrini M, Meggendorfer M, Calogero R, Guadagnuolo V, Fontana MC, Bavaro L, Padella A, Zago E, Pagano L, Zanotti R, Scaffidi L, Specchia G, Albano F, Merante S, Elena C, Savini P, Gangemi D, Tosi P, Ciceri F, Poletti G, Riccioni L, Morigi F, Delledonne M, Haferlach T, Cavo M, Valent P, Soverini S.
Leukemia 2018; 32(1): 139-48
Katrien Lagrou:
- Monitoring of Fluconazole and Caspofungin Activity against In Vivo Candida glabrata Biofilms by Bioluminescence Imaging.
Persyn A, Rogiers O, Brock M, Vande Velde G, Lamkanfi M, Jacobsen ID, Himmelreich U, Lagrou K, Van Dijck P, Kucharikova S.
Antimicrob Agents Chemother 2019; 63(2) - Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?
Zoran T, Sartori B, Sappl L, Aigner M, Sanchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Cascio GL, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernandez MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Lass-Florl C, Lackner M.
Front Microbiol 2018; 9: 516 - Use of Next-Generation Sequencing for Diagnosis of West Nile Virus Infection in Patient Returning to Belgium from Hungary.
Wollants E, Smolders D, Naesens R, Bruynseels P, Lagrou K, Matthijnssens J, Van Ranst M.
Emerg Infect Dis 2018; 24(12): 2380-2 - Bronchoscopic fibered confocal fluorescence microscopy for longitudinal in vivo assessment of pulmonary fungal infections in free-breathing mice.
Van herp L, Poelmans J, Hillen A, Govaerts K, Belderbos S, Buelens T, Lagrou K, Himmelreich U, Vande Velde G.
Sci Rep 2018; 8(1): 3009 - Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.
Van Dijck P, Sjollema J, Cammue BP, Lagrou K, Berman J, d'Enfert C, Andes DR, Arendrup MC, Brakhage AA, Calderone R, Canton E, Coenye T, Cos P, Cowen LE, Edgerton M, Espinel-Ingroff A, Filler SG, Ghannoum M, Gow NAR, Haas H, Jabra-Rizk MA, Johnson EM, Lockhart SR, Lopez-Ribot JL, Maertens J, Munro CA, Nett JE, Nobile CJ, Pfaller MA, Ramage G, Sanglard D, Sanguinetti M, Spriet I, Verweij PE, Warris A, Wauters J, Yeaman MR, Zaat SAJ, Thevissen K.
Microb Cell 2018; 5(7): 300-26 - Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.
Schauwvlieghe A, Rijnders BJA, Philips N, Verwijs R, Vanderbeke L, Van Tienen C, Lagrou K, Verweij PE, Van de Veerdonk FL, Gommers D, Spronk P, Bergmans D, Hoedemaekers A, Andrinopoulou ER, van den Berg C, Juffermans NP, Hodiamont CJ, Vonk AG, Depuydt P, Boelens J, Wauters J.
Lancet Respir Med 2018; 6(10): 782-92 - Anidulafungin increases the antibacterial activity of tigecycline in polymicrobial Candida albicans/Staphylococcus aureus biofilms on intraperitoneally implanted foreign bodies.
Rogiers O, Holtappels M, Siala W, Lamkanfi M, Van Bambeke F, Lagrou K, Van Dijck P, Kucharikova S.
J Antimicrob Chemother 2018; 73(10): 2806-14 - Triazole resistance surveillance in Aspergillus fumigatus.
Resendiz Sharpe A, Lagrou K, Meis JF, Chowdhary A, Lockhart SR, Verweij PE.
Med Mycol 2018; 56(suppl_1): 83-92 - Multimodal Imaging Approach Enables In Vivo Assessment of Antifungal Treatment in a Mouse Model of Invasive Pulmonary Aspergillosis.
Poelmans J, Himmelreich U, Vanherp L, Zhai L, Hillen A, Holvoet B, Belderbos S, Brock M, Maertens J, Van de Velde G, Lagrou K. A
Antimicrob Agents Chemother 2018; 62(7) - Biological tests carried out on serum/plasma samples from donors of human body material for transplantation: Belgian experience and practical recommendations.
Padalko E, Lagrou K, Delforge ML, Jansens H, Ectors N, Pirnay JP, Klykens J, Sokal E, Muylle L, Libois A, Vanderkelen A, Verbeken G, Matthys C, Goossens D, Hanssens G, Baltes M, Beele H.
Cell Tissue Bank 2018; 19(4): 681-95 - Correction to: Biological tests carried out on serum/plasma samples from donors of human body material for transplantation: Belgian experience and practical recommendations.
Padalko E, Lagrou K, Delforge ML, Jansens H, Ectors N, Pirnay JP, Klykens J, Sokal E, Muylle L, Libois A, Vanderkelen A, Verbeken G, Matthys C, Goossens D, Hanssens G, Baltes M, Beele H.
Cell Tissue Bank 2018; 19(4): 835-6 - Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines.
Mikulska M, Averbuch D, Tissot F, Cordonnier C, Akova M, Calandra T, Ceppi M, Bruzzi P, Viscoli C.
J Infect 2018; 76(1): 20-37 - Galactomannan, a Surrogate Marker for Outcome in Invasive Aspergillosis: Finally Coming of Age.
Mercier T, Guldentops E, Lagrou K, Maertens J.
Front Microbiol 2018; 9: 661 - EQUAL Candida Score: An ECMM score derived from current guidelines to measure QUAlity of Clinical Candidaemia Management.
Mellinghoff SC, Hoenigl M, Koehler P, Kumar A, Lagrou K, Lass-Florl C, Meis JF, Menon V, Rautemaa-Richardson R, Cornely OA.
Mycoses 2018; 61(5): 326-30 - Antifungal Activity of Oleylphosphocholine on In Vitro and In Vivo Candida albicans Biofilms.
Holtappels M, Swinnen E, De Groef L, Wuyts J, Moons L, Lagrou K, Van Dijck P, Kucharikova S.
Antimicrob Agents Chemother 2018; 62(1) - Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together.
Hoenigl M, Gangneux JP, Segal E, Alanio A, Chakrabarti A, Chen SC, Govender N, Hagen F, Klimko N, Meis JF, Pasqualotto AC, Seidel D, Walsh TJ, Lagrou K, Lass-Florl C, Cornely OA.
Mycoses 2018; 61(11): 885-94 - Genetic deficiency of NOD2 confers resistance to invasive aspergillosis.
Gresnigt MS, Cunha C, Jaeger M, Goncalves SM, Malireddi RKS, Ammerdorffer A, Lubbers R, Oosting M, Rasid O, Jouvion G, Fitting C, Jong DJ, Lacerda JF, Campos A, Jr., Melchers WJG, Lagrou K, Maertens J, Kanneganti TD, Carvalho A, Ibrahim-Granet O, van de Veerdonk FL.
Nat Commun 2018; 9(1): 2636 - Clonal Spread of Candida glabrata Bloodstream Isolates and Fluconazole Resistance Affected by Prolonged Exposure: a 12-Year Single-Center Study in Belgium.
Goemaere B, Lagrou K, Spriet I, Hendrickx M, Becker P.
Antimicrob Agents Chemother 2018; 62(8) - Increasing candidaemia incidence from 2004 to 2015 with a shift in epidemiology in patients preexposed to antifungals.
Goemaere B, Becker P, Van Wijngaerden E, Maertens J, Spriet I, Hendrickx M, Lagrou K.
Mycoses 2018; 61(2): 127-33 - A Framework for Understanding the Evasion of Host Immunity by Candida Biofilms.
Garcia-Perez JE, Mathe L, Humblet-Baron S, Braem A, Lagrou K, Van Dijck P, Liston A.
Front Immunol 2018; 9: 538 - Aspergillus fumigatus Detection and Risk Factors in Patients with COPD-Bronchiectasis Overlap.
Everaerts S, Lagrou K, Vermeersch K, Dupont LJ, Vanaudenaerde BM, Janssens W.
Int J Mol Sci 2018; 19(2) - First case of Candida auris infection in Belgium in a surgical patient from Kuwait.
Dewaele K, Frans J, Smismans A, Ho E, Tollens T, Lagrou K.
Acta Clin Belg 2018: 1-8 - Switch in a childhood pneumococcal vaccination programme from PCV13 to PCV10: a defendable approach?
Desmet S, Verhaegen J, Van Ranst M, Peetermans W, Lagrou K.
Lancet Infect Dis 2018; 18(8): 830-1 - Switch in childhood pneumococcal vaccine in Belgium.
Desmet S, Peetermans W, Lagrou K.
Lancet Infect Dis 2018; 18(9): 945-6 - Antibiotic Resistance Plasmids Cointegrated into a Megaplasmid Harboring the blaOXA-427 Carbapenemase Gene.
Desmet S, Nepal S, van Dijl JM, Van Ranst M, Chlebowicz MA, Rossen JW, Van Houdt JKJ, Maes P, Lagrou K, Bathoorn E.
Antimicrob Agents Chemother 2018; 62(3) - Prevalence, geographic risk factor, and development of a standardized protocol for fungal isolation in cystic fibrosis: Results from the international prospective study "MFIP".
Delhaes L, Touati K, Faure-Cognet O, Cornet M, Botterel F, Dannaoui E, Morio F, Le Pape P, Grenouillet F, Favennec L, Le Gal S, Nevez G, Duhamel A, Borman A, Saegeman V, Lagrou K, Gomez E, Carro ML, Canton R, Campana S, Buzina W, Chen S, Meyer W, Roilides E, Simitsopoulou M, Manso E, Cariani L, Biffi A, Fiscarelli E, Ricciotti G, Pihet M, Bouchara JP.
J Cyst Fibros 2018 - Active neuroborreliosis or inflammation: are the diagnostic guidelines at stake?
De Cauwer H, Lagrou K, Coeckelbergh E, Bogaerts A, Leenders J, Vanneste D.
Acta Neurol Belg 2018 - ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients.
Cesaro S, Dalianis T, Hanssen Rinaldo C, Koskenvuo M, Pegoraro A, Einsele H, Cordonnier C, Hirsch HH.
J Antimicrob Chemother 2018; 73(1): 12-21 - Distribution of HCV genotypes in Belgium from 2008 to 2015.
Bouacida L, Suin V, Hutse V, Boudewijns M, Cartuyvels R, Debaisieux L, De Laere E, Hallin M, Hougardy N, Lagrou K, Oris E, Padalko E, Reynders M, Roussel G, Senterre JM, Stalpaert M, Ursi D, Vael C, Vaira D, Van Acker J, Verstrepen W, Van Gucht S, Kabamba B, Quoilin S, Muyldermans G.
PLoS One 2018; 13(12): e0207584 - Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus.
Arendrup MC, Verweij PE, Mouton JW, Lagrou K, Meletiadis J.
J Antimicrob Chemother 2018; 73(8): 2274 - Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Florl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Bruggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Loffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinko J, Skiada A, Vehreschild M, Viscoli C, Cornely OA.
Clin Microbiol Infect 2018; 24 Suppl 1: e1-e38 - How to: EUCAST recommendations on the screening procedure E.Def 10.1 for the detection of azole resistance in Aspergillus fumigatus isolates using four-well azole-containing agar plates.
Guinea J, Verweij PE, Meletiadis J, Mouton JW, Barchiesi F, Arendrup MC.
Clin Microbiol Infect 2018
Paul E. Verweij:
- Discovery and characterization of novel Aspergillus fumigatus mycoviruses.
Zoll J, Verweij PE, Melchers WJG.
PLoS One 2018; 13(7): e0200511 - Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment.
Vanderbeke L, Spriet I, Breynaert C, Rijnders BJA, Verweij PE, Wauters J.
Curr Opin Infect Dis 2018; 31(6): 471-80 - Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.
Van Dijck P, Sjollema J, Cammue BP, Lagrou K, Berman J, d'Enfert C, Andes DR, Arendrup MC, Brakhage AA, Calderone R, Canton E, Coenye T, Cos P, Cowen LE, Edgerton M, Espinel-Ingroff A, Filler SG, Ghannoum M, Gow NAR, Haas H, Jabra-Rizk MA, Johnson EM, Lockhart SR, Lopez-Ribot JL, Maertens J, Munro CA, Nett JE, Nobile CJ, Pfaller MA, Ramage G, Sanglard D, Sanguinetti M, Spriet I, Verweij PE, Warris A, Wauters J, Yeaman MR, Zaat SAJ, Thevissen K.
Microb Cell 2018; 5(7): 300-26 - Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.
Schauwvlieghe A, Rijnders BJA, Philips N, Verwijs R, Vanderbeke L, Van Tienen C, Lagrou K, Verweij PE, Van de Veerdonk FL, Gommers D, Spronk P, Bergmans D, Hoedemaekers A, Andrinopoulou ER, van den Berg C, Juffermans NP, Hodiamont CJ, Vonk AG, Depuydt P, Boelens J, Wauters J.
Lancet Respir Med 2018; 6(10): 782-92 - The diagnosis and treatment of invasive aspergillosis in Dutch haematology units facing a rapidly increasing prevalence of azole-resistance.
Schauwvlieghe A, de Jonge N, van Dijk K, Verweij PE, Bruggemann RJ, Biemond BJ, Bart A, von dem Borne PA, Verbon A, van der Beek MT, Demandt AMP, Oudhuis GJ, Cornelissen JJ, van der Velden W, Span LFR, Kampinga GA, Bruns AH, Vonk AG, Haas PA, Doorduijn JK, Rijnders BJA.
A nationwide survey and rationale for the DB-MSG 002 study protocol. Mycoses 2018 - Triazole resistance surveillance in Aspergillus fumigatus.
Resendiz Sharpe A, Lagrou K, Meis JF, Chowdhary A, Lockhart SR, Verweij PE.
Med Mycol 2018; 56(suppl_1): 83-92 - Epidemiology and aetiologies of cryptococcal meningitis in Africa, 1950-2017: protocol for a systematic review.
Nyazika TK, Tatuene JK, Kenfak-Foguena A, Verweij PE, Meis JF, Robertson VJ, Hagen F.
BMJ Open 2018; 8(7): e020654 - Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study.
Lestrade PP, Bentvelsen RG, Schauwvlieghe A, Schalekamp S, van der Velden W, Kuiper EJ, van Paassen J, van der Hoven B, van der Lee HA, Melchers WJG, de Haan AF, van der Hoeven HL, Rijnders BJA, van der Beek MT, Verweij PE.
Clin Infect Dis 2018 - Prevalence and diversity of filamentous fungi in the airways of cystic fibrosis patients - A Dutch, multicentre study.
Engel TGP, Slabbers L, de Jong C, Melchers WJG, Hagen F, Verweij PE, Merkus P, Meis JF.
J Cyst Fibros 2018 - Genotyping of Aspergillus fumigatus in Formalin-Fixed Paraffin-Embedded Tissues and Serum Samples From Patients With Invasive Aspergillosis.
De Groot T, Hagen F, Vreuls W, Verweij PE, Chowdhary A, Meis JF.
Front Cell Infect Microbiol 2018; 8: 377 - Elevated MIC Values of Imidazole Drugs against Aspergillus fumigatus Isolates with TR34/L98H/S297T/F495I Mutation.
Chen Y, Li Z, Han X, Tian S, Zhao J, Chen F, Su X, Zhao J, Zou Z, Gong Y, Qu F, Qiu G, Wang S, Jia X, Lu Z, Hu M, Huang L, Verweij PE, Han L.
Antimicrob Agents Chemother 2018; 62(5) - Molecular Detection of Azole-Resistant Aspergillus fumigatus in Clinical Samples.
Buil JB, Zoll J, Verweij PE, Melchers WJG.
Front Microbiol 2018; 9: 515 - Itraconazole, Voriconazole, and Posaconazole CLSI MIC Distributions for Wild-Type and Azole-Resistant Aspergillus fumigatus Isolates.
Buil JB, Hagen F, Chowdhary A, Verweij PE, Meis JF.
J Fungi (Basel) 2018; 4(3) - Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.
Buil JB, Bruggemann RJM, Wasmann RE, Zoll J, Meis JF, Melchers WJG, Mouton JW, Verweij PE.
J Antimicrob Chemother 2018; 73(1): 263 - Gene co-expression analysis identifies gene clusters associated with isotropic and polarized growth in Aspergillus fumigatus conidia.
Baltussen TJH, Coolen JPM, Zoll J, Verweij PE, Melchers WJG.
Fungal Genet Biol 2018; 116: 62-72 - In-host microevolution of Aspergillus fumigatus: A phenotypic and genotypic analysis.
Ballard E, Melchers WJG, Zoll J, Brown AJP, Verweij PE, Warris A.
Fungal Genet Biol 2018; 113: 1-13 - Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus.
Arendrup MC, Verweij PE, Mouton JW, Lagrou K, Meletiadis J.
J Antimicrob Chemother 2018; 73(8): 2274 - Fusarium metavorans sp. nov.: The frequent opportunist 'FSSC6'.
Al-Hatmi AMS, Ahmed SA, van Diepeningen AD, Drogari-Apiranthitou M, Verweij PE, Meis JF, de Hoog GS.
Med Mycol 2018; 56(suppl_1): 144-52
Stefan Zimmerli:
- Fluconazole non-susceptible breakthrough candidemia after prolonged low-dose prophylaxis: a prospective FUNGINOS study.
Orasch C, Mertz D, Garbino J, van Delden C, Emonet S, Schrenzel J, Zimmerli S, Damonti L, Muhlethaler K, Imhof A, Ruef C, Fehr J, Zbinden R, Boggian K, Bruderer T, Fluckiger U, Conen A, Khanna N, Frei R, Bregenzer T, Lamoth F, Erard V, Bochud PY, Calandra T, Bille J, Marchetti O.
J Infect 2018; 76(5): 489-95 - Correction to: Catheter retention as a consequence rather than a cause of unfavorable outcome in candidemia.
Damonti L, Erard V, Garbino J, Schrenzel J, Zimmerli S, Muhlethaler K, Imhof A, Zbinden R, Fehr J, Boggian K, Bruderer T, Fluckiger U, Frei R, Orasch C, Conen A, Khanna N, Bregenzer T, Bille J, Lamoth F, Marchetti O, Bochud PY.
Intensive Care Med 2018; 44(3): 405-7 - Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease.
Cornely OA, Robertson MN, Haider S, Grigg A, Geddes M, Aoun M, Heinz WJ, Raad I, Schanz U, Meyer RG, Hammond SP, Mullane KM, Ostermann H, Ullmann AJ, Zimmerli S, Van Iersel M, Hepler DA, Waskin H, Kartsonis NA, Maertens J.
J Antimicrob Chemother 2017; 72(12): 3501
Zdenek Racil:
- Analysis of Real-world Data on Postremission Therapy for Acute Myeloid Leukemia With Intermediate Risk Cytogenetics in First Complete Remission.
Vydra J, Salek C, Schwarz J, Zak P, Novak J, Petecukova V, Pecherkova P, Mayer J, Cetkovsky P, Racil Z.
Clin Lymphoma Myeloma Leuk 2018; 18(2): 106-13 - Inflammatory bowel disease and Clostridium difficile infection: contrasting views of international clinical professionals.
Stallmach A, Anttila VJ, Hell M, Gwynn S, Merino-Amador P, Petrosillo N, Racil Z, Warren T, Wenisch C, Wilcox M.
Z Gastroenterol 2018 - Detection and identification of fungi in bronchoalveolar lavage fluid from immunocompromised patients using panfungal PCR.
Ricna D, Lengerova M, Bezdicek M, Kocmanova I, Drgona L, Weinbergerova B, Mayer J, Racil Z.
Folia Microbiol (Praha) 2018 - Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy.
Racil Z, Koritakova E, Sacha T, Klamova H, Belohlavkova P, Faber E, Rea D, Malaskova L, Prochazkova J, Zackova D, Voglova J, Waclaw J, Cetkovsky P, Zak P, Mayer J.
Am J Hematol 2018; 93(10): E342-e5 - European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia.
Maertens JA, Girmenia C, Bruggemann RJ, Duarte RF, Kibbler CC, Ljungman P, Racil Z, Ribaud P, Slavin MA, Cornely OA, Peter Donnelly J, Cordonnier C.
J Antimicrob Chemother 2018; 73(12): 3221-30 - Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin.
Kuzelova K, Brodska B, Schetelig J, Rollig C, Racil Z, Walz JS, Helbig G, Fuchs O, Vrana M, Pecherkova P, Salek C, Mayer J.
PLoS One 2018; 13(12): e0204290 - Chromothripsis in acute myeloid leukemia: biological features and impact on survival.
Fontana MC, Marconi G, Feenstra JDM, Fonzi E, Papayannidis C, Ghelli Luserna di Rora A, Padella A, Solli V, Franchini E, Ottaviani E, Ferrari A, Baldazzi C, Testoni N, Iacobucci I, Soverini S, Haferlach T, Guadagnuolo V, Semerad L, Doubek M, Steurer M, Racil Z, Paolini S, Manfrini M, Cavo M, Simonetti G, Kralovics R, Martinelli G.
Leukemia 2018; 32(7): 1609-20 - JAK2V617F but not CALR mutations confer increased molecular responses to interferon-alpha via JAK1/STAT1 activation.
Czech J, Cordua S, Weinbergerova B, Baumeister J, Crepcia A, Han L, Maie T, Costa IG, Denecke B, Maurer A, Schubert C, Feldberg K, Gezer D, Brummendorf TH, Muller-Newen G, Mayer J, Racil Z, Kubesova B, Knudsen T, Sorensen AL, Holmstrom M, Kjaer L, Skov V, Larsen TS, Hasselbalch HC, Chatain N, Koschmieder S.
Leukemia 2018 - The influence of mutational status and biological characteristics of acute myeloid leukemia on xenotransplantation outcomes in NOD SCID gamma mice.
Culen M, Kosarova Z, Jeziskova I, Folta A, Chovancova J, Loja T, Tom N, Bystry V, Janeckova V, Dvorakova D, Mayer J, Racil Z.
J Cancer Res Clin Oncol 2018; 144(7): 1239-51 - The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients.
Belohlavkova P, Vrbacky F, Voglova J, Racil Z, Zackova D, Hrochova K, Malakova J, Mayer J, Zak P.
Arch Med Sci 2018; 14(6): 1416-23
Hamdi Akan:
- Toxoplasmosis in Transplant Recipients, Europe, 2010-2014.
Robert-Gangneux F, Meroni V, Dupont D, Botterel F, Garcia JMA, Brenier-Pinchart MP, Accoceberry I, Akan H, Abbate I, Boggian K, Bruschi F, Carratala J, David M, Drgona L, Djurkovic-Djakovic O, Farinas MC, Genco F, Gkrania-Klotsas E, Groll AH, Guy E, Hirzel C, Khanna N, Kurt O, Junie LM, Lazzarotto T, Len O, Mueller NJ, Munoz P, Pana ZD, Roilides E, Stajner T, van Delden C, Villena I, Pelloux H, Manuel O.
Emerg Infect Dis 2018; 24(8): 1497-504 - ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Introduction).
Fernandez-Ruiz M, Meije Y, Manuel O, Akan H, Carratala J, Aguado JM, Delaloye J.
Clin Microbiol Infect 2018; 24 Suppl 2: S2-s9 - Is cytomegalovirus a risk factor for haemorrhagic cystitis in allogeneic haematopoietic stem cell transplantation recipients?
Atilla E, Yalciner M, Atilla PA, Ates C, Bozdag SC, Yuksel MK, Toprak SK, Gunduz M, Ozen M, Akan H, Demirer T, Arslan O, Ilhan O, Beksac M, Ozcan M, Gurman G, Topcuoglu P.
Antivir Ther 2018; 23(8): 647-53
Martin Hoenigl:
- Bronchoalveolar lavage Aspergillus Galactomannan lateral flow assay versus Aspergillus-specific lateral flow device test for diagnosis of invasive pulmonary Aspergillosis in patients with hematological malignancies.
Jenks JD, Mehta SR, Taplitz R, Law N, Reed SL, Hoenigl M.
J Infect 2019; 78(3): 249-59 - Point-of-care diagnosis of invasive aspergillosis in non-neutropenic patients: Aspergillus Galactomannan Lateral Flow Assay
versus Aspergillus-specific Lateral Flow Device test in bronchoalveolar lavage.
Jenks JD, Mehta SR, Taplitz R, Aslam S, Reed SL, Hoenigl M.
Mycoses 2019; 62(3): 230-6 - Serum 1,3-Beta-D-Glucan Values During and After Laparoscopic and Open Intestinal Surgery.
Szyszkowitz A, Zurl C, Herzeg A, Berger A, Gemes G, Mitteregger M, Pruller F, Prattes J, Zollner-Schwetz I, Valentin T, Hoenigl M, Krause R.
Open Forum Infect Dis 2018; 5(12): ofy296 - Hotspots of Transmission Driving the Local Hiv Epidemic in the Cologne-Bonn Region, Germany.
Stecher M, Hoenigl M, Eis-Hubinger AM, Lehmann C, Fatkenheuer G, Wasmuth JC, Knops E, Vehreschild JJ, Mehta S, Chaillon A.
Clin Infect Dis 2018 - Molecular Epidemiology of the HIV Epidemic in Three German Metropolitan Regions - Cologne/Bonn, Munich and Hannover, 1999-2016.
Stecher M, Chaillon A, Eberle J, Behrens GMN, Eis-Hubinger AM, Lehmann C, Jablonka A, Bogner J, Fatkenheuer G, Spinner CD, Wasmuth JC, Kaiser R, Mehta SR, Vehreschild JJ, Hoenigl M.
Sci Rep 2018; 8(1): 6799 - Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia.
Salzer HJF, Schafer G, Hoenigl M, Gunther G, Hoffmann C, Kalsdorf B, Alanio A, Lange C.
Respiration 2018; 96(1): 52-65 - Evaluation of Galactomannan Testing, the Aspergillus-Specific Lateral-Flow Device Test and Levels of Cytokines in Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis.
Salzer HJF, Prattes J, Flick H, Reimann M, Heyckendorf J, Kalsdorf B, Obersteiner S, Gaede KI, Herzmann C, Johnson GL, Lange C, Hoenigl M.
Front Microbiol 2018; 9: 2223 - Evaluation of the new AspID polymerase chain reaction assay for detection of Aspergillus species: A pilot study.
Prattes J, Hoenigl M, Zinke SE, Heldt S, Eigl S, Johnson GL, Bustin S, Stelzl E, Kessler HH.
Mycoses 2018; 61(6): 355-9 - EQUAL Candida Score: An ECMM score derived from current guidelines to measure QUAlity of Clinical Candidaemia Management.
Mellinghoff SC, Hoenigl M, Koehler P, Kumar A, Lagrou K, Lass-Florl C, Meis JF, Menon V, Rautemaa-Richardson R, Cornely OA.
Mycoses 2018; 61(5): 326-30 - A Simple Symptom Score for Acute Human Immunodeficiency Virus Infection in a San Diego Community-Based Screening Program.
Lin TC, Gianella S, Tenenbaum T, Little SJ, Hoenigl M.
Clin Infect Dis 2018; 67(1): 105-11 - Brief Report: The Amsterdam Symptom and Risk-Based Score Predicts for Acute HIV Infection in Men Who Have Sex With Men in San Diego.
Lin TC, Dijkstra M, De Bree GJ, Schim van der Loeff MF, Hoenigl M.
J Acquir Immune Defic Syndr 2018; 79(2): e52-e5 - Antifungal Prophylaxis with Posaconazole Delayed-Release Tablet and Oral Suspension in a Real-Life Setting: Plasma Levels, Efficacy, and Tolerability.
Lenczuk D, Zinke-Cerwenka W, Greinix H, Wolfler A, Prattes J, Zollner-Schwetz I, Valentin T, Lin TC, Meinitzer A, Hoenigl M, Krause R.
Antimicrob Agents Chemother 2018; 62(6) - Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy.
Jenks JD, Salzer HJ, Prattes J, Krause R, Buchheidt D, Hoenigl M.
Drug Des Devel Ther 2018; 12: 1033-44 - Treatment of Aspergillosis.
Jenks JD, Hoenigl M.
J Fungi (Basel) 2018; 4(3) - M. CD4:CD8 ratio and CD8+ cell count for prognosticating mortality in HIV-infected patients on antiretroviral therapy.
Jenks JD, Hoenigl
J Lab Precis Med 2018; 3 - Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study.
Hoenigl M, Prattes J, Neumeister P, Wolfler A, Krause R.
Mycoses 2018; 61(3): 201-5 - Soluble Urokinase Plasminogen Activator Receptor (suPAR) is predictive of Non-AIDS Events during Antiretroviral Therapy-mediated Viral Suppression.
Hoenigl M, Moser C, Funderburg N, Bosch R, Kantor A, Zhang Y, Eugen-Olsen J, Finkelman M, Reiser J, Landay A, Moisi D, Lederman MM, Gianella S.
Clin Infect Dis 2018 - Substance Use and Adherence to HIV Preexposure Prophylaxis for Men Who Have Sex with Men(1).
Hoenigl M, Jain S, Moore D, Collins D, Sun X, Anderson PL, Corado K, Blumenthal JS, Daar ES, Milam J, Dube MP, Morris S.
Emerg Infect Dis 2018; 24(12) - Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together.
Hoenigl M, Gangneux JP, Segal E, Alanio A, Chakrabarti A, Chen SC, Govender N, Hagen F, Klimko N, Meis JF, Pasqualotto AC, Seidel D, Walsh TJ, Lagrou K, Lass-Florl C, Cornely OA.
Mycoses 2018; 61(11): 885-94 - Clinical evaluation of the newly formatted lateral-flow device for invasive pulmonary aspergillosis.
Hoenigl M, Eigl S, Heldt S, Duettmann W, Thornton C, Prattes J.
Mycoses 2018; 61(1): 40-3 - M. Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples.
Heldt S, Prattes J, Eigl S, Spiess B, Flick H, Rabensteiner J, Johnson G, Pruller F, Wolfler A, Niedrist T, Boch T, Neumeister P, Strohmaier H, Krause R, Buchheidt D, Hoenigl
J Infect 2018; 77(3): 235-41 - Denning DW, Page ID, Chakaya J, Jabeen K, Jude CM, Cornet M, Alastruey-Izquierdo A, Bongomin F, Bowyer P, Chakrabarti A, Gago S, Guto J, Hochhegger B, Hoenigl M, Irfan M, Irurhe N, Izumikawa K, Kirenga B, Manduku V, Moazam S, Oladele RO, Richardson MD, Tudela JLR, Rozaliyani A, Salzer HJF, Sawyer R, Simukulwa NF, Skrahina A, Sriruttan C, Setianingrum F, Wilopo BAP, Cole DC, Getahun H. Case Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained Settings. Emerg Infect Dis 2018; 24(8)
- Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units.
Bassetti M, Scudeller L, Giacobbe DR, Lamoth F, Righi E, Zuccaro V, Grecchi C, Rebuffi C, Akova M, Alastruey-Izquierdo A, Arikan-Akdagli S, Azoulay E, Blot SI, Cornely OA, Lass-Florl C, Koehler P, Cuenca-Estrella M, de Lange DW, De Rosa FG, De Waele JJ, Dimopoulos G, Garnacho-Montero J, Hoenigl M, Kanj SS, Maertens J, Martin-Loeches I, Munoz P, Kullberg BJ, Agvald-Ohman C, Poulakou G, Rello J, Sanguinetti M, Taccone FS, Timsit JF, Torres A, Vazquez JA, Calandra T.
Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project. Mycoses 2018 - Treatment of Chronic Pulmonary Aspergillosis: Current Standards and Future Perspectives.
Alastruey-Izquierdo A, Cadranel J, Flick H, Godet C, Hennequin C, Hoenigl M, Kosmidis C, Lange C, Munteanu O, Page I, Salzer HJF.
Respiration 2018; 96(2): 159-70 - Levels of interleukin (IL)-6 and IL-8 are elevated in serum and bronchoalveolar lavage fluid of haematological patients with invasive pulmonary aspergillosis.
Heldt S, Eigl S, Prattes J, Flick H, Rabensteiner J, Pruller F, Niedrist T, Neumeister P, Wolfler A, Strohmaier H, Krause R, Hoenigl M.
Mycoses 2017; 60(12): 818-25 - The evolving landscape of new diagnostic tests for invasive aspergillosis in hematology patients: strengths and weaknesses.
Buchheidt D, Reinwald M, Hoenigl M, Hofmann WK, Spiess B, Boch T.
Curr Opin Infect Dis 2017; 30(6): 539-44
Nikolai Klimko:
- Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope((R)).
Seidel D, Meissner A, Lackner M, Piepenbrock E, Salmanton-Garcia J, Stecher M, Mellinghoff S, Hamprecht A, Duran Graeff L, Kohler P, Cheng MP, Denis J, Chedotal I, Chander J, Pakstis DL, Los-Arcos I, Slavin M, Montagna MT, Caggiano G, Mares M, Trauth J, Aurbach U, Vehreschild M, Vehreschild JJ, Duarte RF, Herbrecht R, Wisplinghoff H, Cornely OA.
Crit Rev Microbiol 2019: 1-21 - Rhodotorula infection in haematological patient: Risk factors and outcome.
Potenza L, Chitasombat MN, Klimko N, Bettelli F, Dragonetti G, Del Principe MI, Nucci M, Busca A, Fracchiolla N, Sciume M, Spolzino A, Delia M, Mancini V, Nadali GP, Dargenio M, Shadrivova O, Bacchelli F, Aversa F, Sanguinetti M, Luppi M, Kontoyiannis DP, Pagano L.
Mycoses 2019; 62(3): 223-9 - Zoran T, Sartori B, Sappl L, Aigner M, Sanchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Lo Cascio G, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernandez MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Lass-Florl C, Lackner M. Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon? Frontiers in Microbiology 2018; 9
- Vasilyeva NV, Raush E, Rudneva M, Bogomolova T, Taraskina A, Fang Y, Zhang FM, Klimko N. Etiology of invasive candidosis agents in Russia: a multicenter epidemiological survey. Frontiers of Medicine 2018; 12(1): 84-91
- Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Florl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Bruggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Loffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinko J, Skiada A, Vehreschild M, Viscoli C, Cornely OA.
Clinical Microbiology and Infection 2018; 24: E1-E38 - CXCL10 gene promoter polymorphism A-1447 G increase susceptibility to invasive aspergillosis in female oncohematological patients.
Taraskina A, Rudneva MV, Shadrivova OV, Frolova EV, Bogomolova TS, Klimko NN, Vasilyeva NV.
Medical Mycology 2018; 56: S153-S - Challenges in the diagnosis and treatment of mucormycosis.
Skiada A, Lass-Floerl C, Klimko N, Ibrahim A, Roilides E, Petrikkos G.
Medical Mycology 2018; 56: S93-S101 - Abdominal organs involvement in patients with invasive aspergillosis: results of the multicenter study in Saint Petersburg, Russia.
Shadrivova OV, Shevyakov MA, Desyatik EA, Ignatyeva SM, Zjuzgin IS, Chudinovskih JA, Uspenskaya OS, Terskova TV, Luft AV, Popova MO, Volkova AG, Zubarovskaya LS, Afanasyev BV, Klimko NN.
Medical Mycology 2018; 56: S74-S - Pneumocystis jirovecii pneumonia in patientswith hematological diseases after hematopoietic stem cell transplantation and chemotherapy.
Rogacheva YA, Popova MO, Volkova AG, Ekushev KA, Pirogova OV, Pinegina ON, Ignatieva SM, Bogomolova TS, Paina OV, Bykova TA, Darskaya EI, Vladovskaya MD, Smirnov BI, Moiseev IS, Bondarenko SN, Zubarovskaya LS, Klimko NN, Afanasyev BV.
Medical Mycology 2018; 56: S69-S - Mucormycosis in patients with hematological diseases after hematopoietic stem cell transplantation and chemotherapy.
Rogacheva YA, Popova MO, Volkova AG, Ekushev KA, Pirogova OV, Pinegina ON, Ignatieva SM, Bogomolova TS, Paina OV, Bykova TA, Darskaya EI, Vladovskaya MD, Smirnov BI, Moiseev IS, Bondarenko SN, Zubarovskaya LS, Klimko NN, Afanasyev BV.
Medical Mycology 2018; 56: S13-S - Clinical features of invasive aspergillosis of the paranasal sinuses in St. Petersburg, Russia.
Podkovalnikov SL, Shadrivova OV, Bogomolova TS, Ignatyeva SM, Vasilyeva NV, Klimko NN, Zubarovskaya LS, Afanasyev BV, Artyushkin SA.
Medical Mycology 2018; 56: S84-S - Immunological biomarkers of allergic bronchopulmonary aspergillosis in patients with asthma.
Kozlova YI, Frolova EV, Uchevatkina AE, Filippova LV, Sobolev AV, Nikitin OA, Klimko NN.
Medical Mycology 2018; 56: S75-S - Immunological characteristics of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.
Kozlova YI, Borzova YV, Suslova IE, Frolova EV, Uchevatkina AE, Filippova LV, Aak OV, Ponnaia VA, Klimko NN.
Medical Mycology 2018; 56: S75-S - Case report Chronic Mucocutaneous Candidiasis Caused by Azole-Resistant Candida albicans.
Kozlova O, Frolova E, Bogomolova T, Vybornova E, Yakovleva Y, Klimko N.
Medical Mycology 2018; 56: S102-S - An Estimate of Severe and Chronic Fungal Diseases in the Republic of Kazakhstan.
Kemaykin VM, Tabinbaev NB, Khudaibergenova MS, Olifirovich AA, Abdrakhmanova LM, Denning DW, Klimko N.
J Fungi (Basel) 2018; 4(1) - Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together.
Hoenigl M, Gangneux JP, Segal E, Alanio A, Chakrabarti A, Chen SCA, Govender N, Hagen F, Klimko N, Meis JF, Pasqualotto AC, Seidel D, Walsh TJ, Lagrou K, Lass-Florl C, Cornely OA, Ecmm.
Mycoses 2018; 61(11): 885-94 - How to: EUCAST recommendations on the screening procedure E.Def 10.1 for the detection of azole resistance in Aspergillus fumigatus isolates using four-well azole-containing agar plates.
Guinea J, Verweij PE, Meletiadis J, Mouton JW, Barchiesi F, Arendrup MC.
Clin Microbiol Infect 2018 - Retrospective surveillance of antibiotic use in maternity wards and neonatal intensive care units in Saint Petersburg, Russia.
Galankin TL, Kolbin AS, Sidorenko SV, Kurylev AA, Malikova EA, Lobzin YV, Ivanov DO, Shabalov NP, Mikhailov AV, Klimko NN, Dolgov GV.
Eur J Clin Microbiol Infect Dis 2018; 37(8): 1531-7 - Changing etiology of chronic recurrent vulvovaginal candidosis in 2003-2016 in saint-petersburg, Russia.
Dolgo-Saburova Y, Zhorzh O, Vibornova I, Shurpitskaya O, Raush E, Bogomolova T, Klimko N.
Medical Mycology 2018; 56: S158-S - First case of non-imported pulmonary coccidioidomycosis in Russia.
Desyatik EA, Shadrivova OV, Borzova JV, Mitrofanov VS, Krivolapov YA, Frolova EV, Vasileva NV, Klimko NN.
Medical Mycology 2018; 56: S85-S - Invasive aspergillosis in patients with hodgkin and non-hodgkin lymphoma.
Chudinovskikh J, Semiglazova T, Shadrivova O, Frolova E, Bogomolova T, Ignatyeva S, Alekseev S, Zuzgin I, Harchenko E, Oleinik J, Smirnova A, Klimko N.
Medical Mycology 2018; 56: S97-S - Aspergillosis in Cystic Fibrosis Patients in Russia - the results of a prospective research.
Borzova YV, Suslova IE, Kozlova YI, Bogomolova TS, Ignateva SI, Aak OV, Melekhina JE, Stepanenko TA, Filippova TA, Mahmutova VR, Orlov AV, Krasovskiy SA, Klimko NN, Vasilyeva NV.
Medical Mycology 2018; 56: S102-S - Epidemiology and treatment of fungal keratitis in Saint Petersburg, Russia.
Bogomolova TS, Skryabina EV, Chilina GA, Vasilyeva NV, Klimko NN.
Medical Mycology 2018; 56: S103-S
Back